In Focus channel feed – Endpoints News

In Focus channel feed

‘Harder to find homes’: Latest wave of biotech layoffs could test the industry

3 years ago

A radioactive prostate cancer therapy is a last lifeline for patients. Novartis can't make enough of it

3 years ago

Decades after breakthrough, scientists still puzzling over mRNA delivery

3 years ago

Thousands of gene and cell therapies are inundating FDA reviewers as the agency tries to keep up

3 years ago

How Purdue's $272M addiction payout funded a new home for its discarded non-opioid research

3 years ago

A stem cell pioneer sent an experiment into space. Patients are the next frontier

3 years ago

The conference is back. What about the industry? Taking the biotech pulse at #JPM23

3 years ago

As money pours into digital therapeutics, insurance coverage crawls

3 years ago

Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?

3 years ago

A biotech paused a gene therapy hatched by families. Now they want control

3 years ago

Father starts lab after intellectual property issues stymie rare disease drug development

3 years ago

Even as pandemic recedes, short-staffed trial sites leave cancer patients waiting

3 years ago

China's DNA giant confronts skepticism in US expansion bid

3 years ago

After years of failures, the hunt for a new type of Parkinson’s drug is on

3 years ago

Biotech's 'sugar high' led to a correction, but winter doldrums could make way for a turnaround story this fall

3 years ago

Biotech’s downturn fuels a billionaire’s niche investment industry

3 years ago

Those big billion-dollar PhIII studies? Martin Landray says they can be done for a tiny fraction of the cost

3 years ago

Why non-opioid pain drugs keep failing — and what's next for the field

3 years ago

An MIT professor's rare disease quest ripples throughout biotech

3 years ago

After Roe, startups seek to fill Big Pharma’s male contraception gap

3 years ago

After abortion ruling, biotechs behind novel contraceptives say tide is turning on insurance coverage

3 years ago

DNA sequencing giant Illumina battles antitrust regulators and growing competition

3 years ago

How prepared is biopharma for the cyber doomsday?

4 years ago

A new era of treatment: How biomarkers are changing the way we think about cancer

4 years ago

First page Previous page 2 3 456 7 8 Next page Last page